Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries.
Luan Y, Yuan Q, Wang Q, Compton S, Wu D, Tang W. Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries. The Journal Of Immunology 2022, 209: 723-730. PMID: 35914834, PMCID: PMC9378470, DOI: 10.4049/jimmunol.2100968.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCOVID-19 Drug TreatmentIndazolesLungLung InjuryMiceMurine hepatitis virusPyrimidinesSulfonamidesConceptsLung injuryCOVID-19 patientsPotential treatmentSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Long-term pathological consequencesRespiratory syndrome coronavirus 2Severe acute respiratory syndromeAdministration of pazopanibAmeliorate lung injuryPulmonary disease modelAcute lung injuryEarly disease manifestationsSyndrome coronavirus 2Acute respiratory syndromeCOVID-19Health care systemCoronavirus 2J miceDisease manifestationsTherapeutic effectVirus infectionRespiratory syndromePazopanibInjury